AzTrials
AzTrials

AtelectasisNCT03112811

Influence of Techniques of Chest Physiotherapy in the Pediatric Intensive Care

A study testing Autogenic drainage and Intrapulmonary percussive ventilation in people with Atelectasis, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to compare the effect of the autogenic drainage and the intrapulmonary percussive ventilation on the levying of the lung atelectasis, by means of the thoracic imaging (thoracic ultrasound and radiography), at the intubated or extubated child with the ventilatory support. Read more about this study

Who is it for?
Ages Up to 16 years
Conditions the study is for
Atelectasis
What is being tested?
Autogenic drainage and Intrapulmonary percussive ventilation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteBelgium
Study dates
3 Apr 2007to 1 Jan 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child < 10 kg
  • Hospitalization in the pediatric intensive care
  • Presence of an atelectasis to the radiography and/or to the lung ultrasound
  • Presence of an invasive ventilation or a non-invasive ventilation
  • Criteria of cardio-respiratory stability met

Who cannot join

  • Absence of the physiotherapist and the radiologist referents (by ex: at night)
  • Prematurity
  • Neuromuscular disease
  • Ventilation by high-frequency oscillation
  • Extraphysical Assistance
  • Patient cardiac post-surgery with closure postponed from the thorax. In the closure of the thorax, the patient becomes eligible
  • Intracranial pressure > 20 mmHg or clinical signs of intracranial high blood pressure

Trial locations and contacts

1 site in 1 country.

Damien Moerman, PT contact

damien.moerman@uclouvain.be

Belgium1 site, 1 recruiting
  • Study site

    Brussels

    Damien M Moerman, PT, damien.moerman@uclouvain.be

    Recruiting

Other trials in Belgium

About this study

Official title: Influence of Techniques of Chest Physiotherapy on the Respiratory Status and the Hemodynamic Impact in the Pediatric Intensive Care

The purpose of this study is to compare the effect of the autogenic drainage and the intrapulmonary percussive ventilation on the levying of the lung atelectasis, by means of the thoracic imaging (thoracic ultrasound and radiography), at the intubated or extubated child with the ventilatory support.

Conditions
Atelectasis
Being tested
Autogenic drainage, Intrapulmonary percussive ventilation
Medical subject headings
Pulmonary Atelectasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Autogenic drainageDevice

    The manual technique of the chest physiotherapy to move the secretions

  • Intrapulmonary percussive ventilationDevice

    The instrumental technique of the chest physiotherapy to move the secretions

Study groups in NCT03112811
Study groupRoleWhat they receive
Intubated infantExperimentalNot described
Receives: Device: Autogenic drainage; Device: Intrapulmonary percussive ventilation
Extubated infantExperimentalNot described
Receives: Device: Autogenic drainage; Device: Intrapulmonary percussive ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline Atelectasis scores at 20 min

    Each atelectasis has a thoracic ultrasound

    Measured: Baseline and at 20 min

  2. Change from baseline cardiac frequency at 20 min, 30 min, 50 min, 80 min

    Stability of the parameters

    Measured: Baseline and at 20 min, 30 min, 50 min, 80 min

  3. Change from baseline respiratory frequency at 20 min, 30 min, 50 min, 80 min

    Stability of the parameters

    Measured: Baseline and at 20 min, 30 min, 50 min, 80 min

  4. Change from baseline systolic blood pressure at 20 min, 30 min, 50 min, 80 min

    Stability of the parameters

    Measured: Baseline and at 20 min, 30 min, 50 min, 80 min

  5. Change from baseline diastolic blood pressure at 20 min, 30 min, 50 min, 80 min

    Stability of the parameters

    Measured: Baseline and at 20 min, 30 min, 50 min, 80 min

  6. Change from baseline oxygen saturation at 20 min, 30 min, 50 min, 80 min

    Stability of the parameters

    Measured: Baseline and at 20 min, 30 min, 50 min, 80 min

  7. Change from baseline expiratory CO2 at 20 min, 30 min, 50 min, 80 min

    Stability of the parameters

    Measured: Baseline and at 20 min, 30 min, 50 min, 80 min

  8. Compare the atelectasis scores

    Compare the atelectasis scores between thoracic ultrasound and chest x-ray

    Measured: Baseline between thoracic ultrasound and chest x-ray

Secondary outcomes (1)
  1. Number of unexpected events

    Pain, desaturation, accidentally extubation

    Measured: At 20 min

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2017
  2. Study start3 Apr 2007
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion1 Jan 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03112811
Sponsor's protocol ID
Atelectasis001
Status last verified
Apr 2017
First submitted
3 Apr 2017
Last updated
13 Apr 2017
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Autogenic drainage and Intrapulmonary percussive ventilation in people with Atelectasis, run by Cliniques universitaires Saint-Luc- Université Catholique de Louvain at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Damien Moerman, PT (damien.moerman@uclouvain.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline Atelectasis scores at 20 min (time frame: Baseline and at 20 min). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in